Effect of cefovecin on the fecal flora of healthy dogs

Veterinary Journal

Volumn 198, Issue 1, 2013, Pages 259-266

  Lawrence, M ^a   KuKanich, K ^a   KuKanich, B ^a   Heinrich, E ^a   Coetzee, J F ^a,b   Grauer, G ^a   Narayanan, S ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial resistance; Cefovecin; E. coli; Enterococci; Gastrointestinal flora

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALEXIN; CEFAZOLIN; CEFOVECIN; CEFPODOXIME; CEFTIOFUR; CEFTRIAXONE; DOXYCYCLINE; ENROFLOXACIN; GENTAMICIN; IMIPENEM;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLA CMV2 GENE; CONTROLLED STUDY; DISK DIFFUSION; DRUG BLOOD LEVEL; DRUG EFFECT; ENTEROCOCCUS; ESCHERICHIA COLI; FECAL COLIFORM; FECES MICROFLORA; FEMALE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; SALMONELLA;

CANIS FAMILIARIS; ENTEROBACTERIACEAE; SALMONELLA;

ANTIMICROBIAL RESISTANCE; CEFOVECIN; E. COLI; ENTEROCOCCI; GASTROINTESTINAL FLORA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEPHALOSPORINS; CHROMATOGRAPHY, LIQUID; COLONY COUNT, MICROBIAL; DOGS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; ESCHERICHIA COLI; FECES; FEMALE; MALE; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; REAL-TIME POLYMERASE CHAIN REACTION; SALMONELLA; TIME FACTORS;

EID: 84887614431     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2013.04.010     Document Type: Article

References (16)

1. Alali W.Q., Scott H.M., Norby B., Gebreyes W., Loneragan G.H. Quantification of the BlaCMY-2 in feces from beef feedlot cattle administered three different doses of ceftiofur in a longitudinal controlled feed trial. Foodborne Pathogens and Disease 2009, 6:917-924.
2. Clinical and Laboratory Standards Institute, 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard CLSI Document M31-A3, vol. 28, Third Ed. Clinical and Laboratory Standards Institute, Wayne, Pa, pp. 1-99.
3. Clinical and Laboratory Standards Institute, 2010. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI Document M100-S20, vol. 30. Clinical and Laboratory Standards Institute, Wayne, Pa, pp. 76-79.
4. Damborg P., Gaustad I.G., Olsen J.E., Guardabassi L. Selection of CMY-2 producing Escherichia coli in the faecal flora of dogs treated with cephalexin. Veterinary Microbiology 2011, 151:404-408.
5. Forward K.R., Matheson K.M., Hiltz M., Musgrave H., Poppe C. Recovery of cephalosporin-resistant Escherichia coli and Salmonella from pork, beef, and chicken marketed in Nova Scotia. The Canadian Journal of Infectious Disease and Medical Microbiology 2004, 15:226-230.
6. Jiang X., Yang H., Dettman B., Doyle M.P. Analysis of fecal microbial flora for antibiotic resistance in ceftiofur-treated calves. Foodborne Pathogens and Disease 2006, 3:355-365.
7. Jackson C.R., Fedorka-Cray P.J., Davis J.A., Barrett J.B., Frye J.G. Prevalence, species distribution, and antimicrobial resistance of enterococci isolated from dogs and cats in the United States. Journal of Applied Microbiology 2009, 107:1269-1278.
8. Kariyama R., Mitsuhata R., Chow J.W., Clewell D.B., Kumon H. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. Journal of Clinical Microbiology 2000, 38:3092-3095.
9. Lowrance T.C., Loneragan G.H., Kunze D.J., Platt T.M., Ives S.E., Scott H.M., Norby B., Echeverry A., Brashears M.M. Changes in antimicrobial susceptibility in a population of Escherichia coli isolated from feedlot cattle administered ceftiofur crystalline-free acid. American Journal of Veterinary Research 2007, 68:501-507.
10. Poyart C., Quesnes G., Trieu-Cuot P. Sequencing the gene encoding manganese-dependent superoxide dismutase for rapid species identification of enterococci. Journal of Clinical Microbiology 2000, 38:415-418.
11. Stegemann M.R., Sherington J., Blanchflower S. Pharmacokinetics and pharmacodynamics of cefovecin in dogs. Journal of Veterinary Pharmacology and Therapeutics 2006, 29:501-511.
12. Stegemann M.R., Passmore C.A., Sherington J., Lindeman C.J., Papp G., Weigel D.J., Skogerboe T.L. Antimicrobial activity and spectrum of cefovecin, a new extended-spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America. Antimicrobial Agents and Chemotherapy 2006, 50:2286-2292.
13. Stenske K.A., Bemis D.A., Gillespie B.E., D'Souza D.H., Oliver S.P., Draughon F.A., Matteson K.J., Bartges J.W. Comparison of clonal relatedness and antimicrobial susceptibility of fecal Escherichia coli from healthy dogs and their owners. American Journal of Veterinary Research 2009, 70:1108-1116.
14. Trott D.J., Filippich L.J., Bensink J.C., Downs M.T., McKenzie S.E., Townsend K.M., Moss S.M., Chinn J.J. Canine model for investigating the impact of oral enrofloxacin on commensal coliforms and colonization with multidrug-resistant Escherichia coli. Journal of Medical Microbiology 2004, 53:1-5.
15. Winokur P.L., Vonstein D.L., Hoffman L.J., Uhlenhopp E.K., Doern G.V. Evidence for transfer of CMY-2 AmpC B-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrobial Agents and Chemotherapy 2001, 45:2716-2722.
16. Zhao S., White D.G., McDermott P.F., Friedman S., English L., Ayers S., Meng J., Maurer J.J., Holland R., Walker R.D. Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrobial Agents and Chemotherapy 2001, 45:3647-3650.